Dedicated to NPs, PAs and rheumatologists who diagnose and treat arthritis and other musculoskeletal conditions.
Search:

key topics



navigation

Assessing Older DMARDs And The Roles Of Diet In Treating RA
Rheumatoid Arthritis Q&A:
Assessing Older DMARDs And The Roles Of Diet In Treating RA

- Clinical Editor: Nathan Wei, MD

In this column, our panelists discuss the possible use of older disease-modifying antirheumatic drugs (DMARDs) in managing rheumatoid arthritis (RA), whether nutrition can have an impact in these patients, and the role of magnetic resonance imaging (MRI) in diagnosing RA and monitoring patient progress. Without further delay, here is what our panelists had to say.


Q: Are there patients for whom you have used older DMARDS such as gold or D-penicillamine? Is there a role at all for these medications?

A: Alan Kivitz, MD, recalls that gold injections became increasingly difficult to obtain from manufacturers back in the pre-biologic era of RA treatment. Given the lack of availability at that time and the availability of other oral agents, Dr. Kivitz says parenteral gold gradually disappeared from his practice. In regard to penicillamine, Dr. Kivitz says it was “always a challenging drug to use,” based upon its toxicity profile and the length of time needed for a response.
Is There A Place For MRI In Diagnosing RA?


“In the current biologic era of RA treatment, we no longer have patients who receive either (gold or D-penicillamine),” notes Dr. Kivitz. “Even in the case of a patient who is not a candidate for biologic therapy or methotrexate, other options still abound that have eclipsed the need for these older agents.”
Nathan Wei, MD, says he has heard about a resurgence of gold at recent conferences. He adds that he is currently trying gold in one patient with RA who has failed a variety of other therapies but has not seen a response as of yet. Dr. Wei notes gold may be worth a try in a small subset of patients but agrees with Dr. Kivitz that the advent of biologic medications have ushered in a “new era” of RA treatment.

Q: What do you tell your patients with RA about the role of diet?
A: This is a controversial area as there is no exact science when it comes to nutrition and its impact on RA, explains Ronald J. Rapoport, MD, Pc, FACR. Dr. Rapoport says numerous anecdotal reports point toward the importance of olive oil, oil rich fish, fruits and vegetables. He also notes that in 2004, an article in The Proceedings of the Nutrition Society mentioned that foods high in polyunsaturated fatty acids, such as fruits, vegetables and other foods high in antioxidants, might be helpful for inflammatory conditions such as RA.1 On the other hand, Dr. Rapoport says one prospective analysis cited red meat as a risk for inflammatory arthritis.2

Dr. Rapoport concedes that some studies have shown that regardless of the dietary intervention, when patients are involved in the treatment of their condition, they get better. He also notes that if a patient is overweight, “that obviously will have an adverse effect on arthritis pain in weightbearing areas.”

Dr. Wei cites a 1980 study that evaluated 22 patients with RA who consumed a diet that excluded common “food allergens.”3 Twenty patients had an improvement in symptoms and 19 stated that specific foods made their symptoms worse. The most common symptom-provoking foods were grains, milk, nuts, beef and eggs.3 Yet Dr. Wei notes that in a 1992 double-blind, controlled study, researchers showed that only nine out of 78 patients with RA who completed the study had a favorable response to diet modification and those nine patients experienced subsequent disease flare during re-challenge.4

While Dr. Wei agrees that the results in the aforementioned studies as well as others in this area vary in the findings. He says the studies overall “seem to suggest that the avoidance of different types of foods might benefit a subset of patients with RA.”5,6

Accordingly, Dr. Wei says food allergy testing is a “viable weapon in the arsenal” of clinicians who treat RA. In his clinic, Dr. Wei considers food allergy testing when patients have symptoms that do not respond to conventional therapies.

Dr. Kivitz is a board-certified rheumatologist and director of the Altoona Arthritis and Osteoporosis Research Center in Altoona, Pa.
Dr. Yocum is a former Professor of Medicine in the division of rheumatology at the University of Arizona. He is now a Director with Genentech.
Dr. Rapoport is the owner of the Truesdale Clinic in Fall River, Mass.
Dr. Wei is a board-certified rheumatologist. He is the Clinical Director of the Arthritis and Osteoporosis Center in Frederick, Md.


1. Yaqoob P. Fatty acids and the immune system: from basic science to clinical applications. Proceedings of the Nutrition Society 2004;63(1):89-104(16).
2. Pattison DJ, Symmons DPM, Lunt M, Welch A, Luben R, et al. Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption. Arthritis Rheum 2004;50(12):3804-3812.
3. Hicklin JA, McEwen LM, Morgan JE. The effect of diet in rheumatoid arthritis. Clin Allergy 1980;10:463.
4. Van de Laar MA, van der Korst JK. Food intolerance in rheumatoid arthritis. I. A double blind, controlled trial of the clinical effects of elimination of milk allergens and azo dyes. Ann Rheum Dis 1992; 51:298-302.
5. Darlington LG, Ramsey NW, Mansfield JR. Placebo-controlled, blind study of dietary manipulation therapy in rheumatoid arthritis. Lancet 1986;1:236-238.
6. Panush RS, Carter RL, Katz P, et al. Diet therapy for rheumatoid arthritis. Arthritis Rheum 1983; 26:462-471.
7. B J Ejbjerg, et al. Optimised, low cost, low field dedicated extremity MRI is highly specific and sensitive for synovitis and bone erosions in rheumatoid arthritis wrist and finger joints: comparison with conventional high field MRI and radiography. Ann Rheum Dis 2005; 64: 1280-1287.

Arthritis Practitioner - ISSN: 1 - Volume 3 - Issue 3 - May 2007 - Pages: 14 - 15



© 2007 HMP Communications | All Rights Reserved
83 General Warren Blvd | Suite 100 | Malvern, PA 19355
Contact Us | Reprints/Permissions


August 28, 2008

Emerging Concepts In Treating Rheumatoid Arthritis

A complimentary CME Webcast Event

To register for this Web Archive program, click on Complimentary CME Webcast Event


This activity is for nurse practitioners, physician assistants, rheumatologists and internal medicine physicians who treat patients with rheumatoid arthritis (RA).


Panelists/Lectures

"What You Should Know About Treating Early RA"
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, Md.

"A Closer Look At The Efficacy And Safety Of Combination Therapy With Anti-TNF Agents"
Philip Mease, MD
Clinical Professor
University of Washington
School of Medicine
Chief, Rheumatology Clinical Research
Swedish Hospital Medical Center
Seattle

"What The Studies Reveal About Emerging Therapies For RA"
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas,Tx.

This activity is supported by an educational grant from Genentech and Biogen Idec. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).


Current Insights On Combination Therapy For Rheumatoid Arthritis

A complimentary CME Webcast Event
ON DEMAND
(Q&A with panelists to follow lectures)

To register for this Webcast program, click on Complimentary CME Webcast


This activity is geared to physicians, rheumatologists, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.

Agenda And Faculty

“Treating RA: The Shift To A More Aggressive Therapeutic Approach”
Linda Davis, MHS, PA-C
Assistant Professor
University Of North Texas Health Science Center

“What The Literature Reveals About Combination Therapy”
Kevin M. Latinis, MD, PhD
Division of Allergy, Clinical Immunology and Rheumatology
University of Kansas Medical Center

“New Biologic DMARDs: Can They Have An Impact?”
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas, Texas

This activity is supported by an educational grant from Bristol-Myers Squibb. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).


A Guide To Viscosupplementation For Osteoarthritis Knee Pain

A complimentary CME Web Archive Event

To register for this Web Archive program, click on Complimentary CME Web Archive Event


This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat osteoarthritis.

Agenda And Faculty

“A Closer Look At The Role Of Intraarticular Injections”
Frank Caruso, PA-C
Physician Assistant
Wake Forest University Baptist Medical Center
Winston-Salem, NC

“What The Literature Reveals About Viscosupplementation”
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, MD

“Mastering The Technique Of Intraarticular Injections”
Mike Rudzinski, PA-C
Physician Assistant
Buffalo Veterans Affairs Medical Center
Buffalo, NY

This activity is supported by an educational grant from Genzyme.
The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).



A Complimentary CME Webcast Event

A Guide To Infusion Therapy For Patients With Rheumatoid Arthritis

A Complimentary, On-Demand CME Webcast

To register for this Webcast program, click on Complimentary CME Webcast Event


This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.

AGENDA and FACULTY

"Reviewing The Role of DMARDs In Treating RA"
Don Flinn, PA-C
Physician Assistant, McBride Clinic, Oklahoma City, Ok.
Vice-President, Society Of Physician Assistants In Rheumatology

"Assessing The Potential of Biologic Therapies"
Mark Genovese, MD
Associate Professor of Medicine
Division of Immunology And Rheumatology
Stanford University School Of Medicine

"What You Should Know About Infusion Therapy"
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, Md.

This activity is supported by an educational grant from Bristol-Myers Squibb.

The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).